[Treatment of carotid stenosis: angioplasty, a well thought-out choice]

Area of Science:

• Vascular biology and cardiovascular medicine

Context:

• Established therapeutic classes for secondary prevention include statins, antiplatelet agents (aspirin, clopidogrel), ACE inhibitors, and beta-blockers.
• Current guidelines lack sufficient data to support routine vasoactive agent use in claudication.
• Critical limb ischemia necessitates immediate pain and infection management, alongside revascularization efforts.

Purpose:

• To outline current therapeutic strategies for secondary prevention in vascular disease.
• To address management of critical limb ischemia.
• To introduce angiogenesis as a potential therapeutic avenue.

Summary:

• Secondary prevention utilizes statins, antiplatelet drugs, ACE inhibitors, and beta-blockers, with benefits comparable to post-myocardial infarction or stroke.
• Critical ischemia management involves pain/infection control, revascularization attempts, and amputation for severe cases like gangrene.
• Angiogenesis, the formation of new blood vessels, encompasses arteriogenesis, angiogenesis, and vasculogenesis, presenting a potential future therapeutic approach.

Impact:

• Provides a concise overview of established and emerging strategies in vascular disease management.
• Highlights critical interventions for limb salvage in severe ischemia.
• Defines key terms in vascular regeneration, paving the way for future research and clinical applications.